Delivery Order SPE2DE24D0013-SPE2D625F8961
- Not listed
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract, worth $1,730.40, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. This award is part of a larger Indefinite Delivery Vehicle (IDV) contract worth $5,000,000 with the Indian Health Service, as well as two other significant IDV...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The contract is a delivery order valued at $13,096.80 with a firm fixed price pricing type and an ultimate completion date of March 31, 2025. The contract was awarded by the Defense Logistics Agency, a defense agency, and is not designated as a set-aside. Cepheid has several...
- This federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, is for the delivery of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The contract has a ceiling value of $8,160.00 and is a firm fixed-price delivery order awarded by the Defense Logistics Agency, an agency within the Department of Defense. The contract is not designated as a set-aside. Cepheid has previously been awarded several Indefinite...
- This federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, was issued by the Defense Logistics Agency, an agency that supports the U.S. Department of Defense. The contract, valued at $27,200.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV)....
- The federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is a firm fixed-price delivery order contract valued at $13,674.60. The contract was awarded by the Defense Logistics Agency, which is the primary logistics and supply chain management agency for the U.S. Department of Defense. The contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such...
- This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is a $13,600.00 firm fixed-price delivery order issued by the Defense Logistics Agency's Medical Supply Chain program. The contract supports the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect a range of infectious diseases such as COVID-19, influenza, and sexually transmitted diseases. Cepheid is an original equipment...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the delivery of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The contract, valued at $7,758.38, is a firm fixed-price delivery order awarded by the Defense Logistics Agency's Medical Supply Chain program. The contract does not have a set-aside designation. Cepheid has been awarded other significant federal contract vehicles,...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The contract is a delivery order with a firm fixed price of $7,416.00 and an ultimate completion date of January 30, 2025. It was awarded by the Defense Logistics Agency, which is the Department of Defense's combat logistics support agency. The contract has no set-aside...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The $7,262.88 firm fixed-price delivery order contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and other conditions. Cepheid holds several significant federal contract Indefinite Delivery...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), which is the Department of Defense's (DoD) combat logistics support agency. The contract, worth $1,750.00, is a delivery order issued under Cepheid's existing Indefinite Delivery Contract (IDC) with the agency. The contract is for firm fixed-price procurement of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F8961Delivery Order
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide the U.S. government with GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The $73,958.40 contract is a firm fixed-price delivery order from the Defense Logistics Agency, which has previously awarded Cepheid several Indefinite Delivery Contracts and Blanket Purchase Agreements to continuously supply molecular diagnostic products and services to agencies like the Department of Veterans Affairs and Indian Health Service. This award does not have a set-aside designation, reflecting Cepheid's status as a prime contractor in the molecular diagnostics field. The contract will support the government's testing needs for infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and other clinical conditions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $74.0k | 10/21/24 |